Moxibustion ameliorates ovarian function in premature ovarian insufficiency rats by activating cAMP/PKA/CREB to promote steroidogenesis in ovarian granulosa cells
article
OA: closed
CC0
Abstract
Premature ovarian insufficiency (POI) presents a substantial challenge to women's physiological and psychological well-being. Hormone replacement therapy, as the preferred therapeutic approach, involves solely exogenous supplementation of estrogen. Moxibustion, a traditional Chinese external treatment, has been investigated in our previous studies. It not only improves hormone levels and clinical symptoms in POI patients but also safeguards ovarian reserve. This study aims to explore the regulatory mechanisms by which moxibustion modulates hormone levels and restores ovarian function in POI. A POI rat model was established using cyclophosphamide, and moxibustion treatment was applied at acupoints "CV4" and "SP6" for a total of four courses. Subsequently, ovaries from each group were subjected to transcriptome sequencing (Bulk RNA-seq). Target pathways and key genes were selected through enrichment analysis and GSVA scoring, with validation using various techniques including electron microscopy, ELISA, Western blot, and immunohistochemistry. The results demonstrated that moxibustion restored the estrous cycle in POI rats, improved sex hormone levels, reduced the number of atretic follicles, and increased the count of dominant follicles (P<0.05). Bulk RNA-seq analysis revealed that moxibustion downregulated pathways associated with ovarian dysfunction, infertility, and immune responses, upregulated pathways related to follicular development and ovarian steroidogenesis. Furthermore, our data confirmed that moxibustion significantly increased the number of ovarian granulosa cells (GCs) and upregulated the expression of proteins related to steroidogenesis in GCs, including FSHR, P450 arom, cAMP, PKA, and CREB (P<0.05), with no significant effect observed on proteins related to steroidogenesis in theca cells. These outcomes aligned with the RNA-seq results. In conclusion, these findings propose that moxibustion enhances steroidogenesis in GCs through the activation of the cAMP/PKA/CREB pathway, consequently improving impaired ovarian function in POI rats. This study provides robust evidence supporting moxibustion as a targeted intervention for treating POI by specifically regulating steroidogenesis in GCs.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (42)
- ESHRE Guideline: management of women with premature ovarian insufficiency via openalex
- W2035618305 via openalex
- W2096790979 via openalex
- W2130410032 via openalex
- W2543454806 via openalex
- W2612313911 via openalex
- W2904669398 via openalex
- W2950595506 via openalex
- W2958422128 via openalex
- W2980216096 via openalex
- W2993086434 via openalex
- W2996834448 via openalex
- W3048544241 via openalex
- W3108997381 via openalex
- W3126444157 via openalex
- W3128991791 via openalex
- W3133673942 via openalex
- W3133922989 via openalex
- W3165475870 via openalex
- W3188619361 via openalex
- W3197207782 via openalex
- W4212825034 via openalex
- W4214537801 via openalex
- W4214593314 via openalex
- W4223933038 via openalex
- W4224210654 via openalex
- W4234792992 via openalex
- W4253545088 via openalex
- W4283758908 via openalex
- W4294216483 via openalex
- W4296083369 via openalex
- W4306966822 via openalex
- W4316174606 via openalex
- W4319878875 via openalex
- W4321490722 via openalex
- W6677128360 via openalex
- W6772060354 via openalex
- W6790938149 via openalex
- W6795984909 via openalex
- W6807845233 via openalex
- W1995012620 via openalex
- W6848737160 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-08-12T06:43:03.944938+00:00
License: CC0
· commercial use OK